Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
Chronic obstructive pulmonary diseases (COPD) and asthma are fatal. The respiratory tract may be blocked, robbed of the adequate amounts of oxygen; hence, death ensues if a quick medical attention is not provided. The treatment available for the duo are inhaled corticosteroids (ICS). The ICS can wor...
Saved in:
Main Authors: | Hilla Mills, Ronald Acquah, Nova Tang, Luke Cheung, Susanne Klenk, Ronald Glassen, Magali Pirson, Alain Albert, Duong Trinh Hoang, Thang Nguyen Van |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Emergency Medicine International |
Online Access: | http://dx.doi.org/10.1155/2022/2593740 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Use of Bacteria in Cancer Treatment: A Review from the Perspective of Cellular Microbiology
by: Hilla Mills, et al.
Published: (2022-01-01) -
Retracted: Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
by: Emergency Medicine International
Published: (2024-01-01) -
Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01) -
Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
by: Kenneth R Chapman, et al.
Published: (1999-01-01) -
Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma
by: Louis-Philippe Boulet, et al.
Published: (2000-01-01)